FDA warning letter · Drugs

Novo Nordisk Inc.

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to Submit Under Form FDA-2253

Citations in the original letter

As cited in this historical letter, not a statement of current regulatory requirements.

  • 21 CFR 202.1
  • 21 CFR 314.81(b)(3)(i)